Preconceptional folate intake and malformations of the cardiac outflow tract

Epidemiology

Volumn 9, Issue 1, 1998, Pages 95-98

  Scanlon, Kelley S ^a,d   Ferencz, Charlotte ^b   Loffredo, Christopher A ^b   Wilson, P David ^b   Correa Villaseñor, Adolfo ^c   Khoury, Muin J ^d   Willett, Walter C ^e   Boughman, Joanne A ^f   Magee, Carol A ^f   Brenner, Joel I ^f   Neill, Catherine A ^f   Perry, Lowell W ^f   Martin, Gerard R ^f   Downing, John W ^f   Mardini, Mohammed K ^f   Hepner, Seymour I ^f  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f NONE

Author keywords

Cardiac outflow tract defects; Cardiovascular malformations; Conotruncal defects; Folate; Folic acid; Multivitamin supplements

Indexed keywords

FOLIC ACID; MULTIVITAMIN;

AORTOPULMONARY SEPTAL DEFECT; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FALLOT TETRALOGY; GREAT VESSELS TRANSPOSITION; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INFANT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; VITAMIN INTAKE;

EID: 0031975890     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-199801000-00019     Document Type: Article

References (20)

1. Shaw GM, O'Malley CD, Wasserman CR, Tolarova MM, Lammer EJ. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet 1995;59:536-545.
2. Botto LD, Khoury MJ, Mulinare J, Erickson JD. Periconceptional use of multivitamins and the prevention of conotruncal heart defects: evidence from a population-based case-control study. Pediatrics 1996;98:911-917.
3. Ferencz C, Brenner JI, Loffredo C, Kappetein AP, Wilson PD. Transposition of the great arteries: etiologic distinctions of outflow tract defects in a case-control study of risk factors. In: Clark EB, Markwald RR, Takao A, eds. Developmental Mechanisms of Heart Disease. Armonk, NY: Futura Publishing, 1995;639-653.
4. Lurie IW, Kappetein AP, Loffredo CA, Ferencz C. Non-cardiac malformations in individuals with outflow tract defects of the heart: the Baltimore Washington Infant Study (1981-1989). Am J Med Genet 1995;59:76-84.
5. Ferencz C, Rubin JD, Loffredo CA, Magee CA, eds. Epidemiology of Congenital Heart Disease: The Baltimore-Washington Infant Study 1981-1989. Armonk, NY: Futura Publishing, 1993.
6. Willett WC, Sampson L, Browne ML, Stampfer MJ, Rosner B, Hennekens CH, Speizer FE. Comparison of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol 1988;127:188-199.
7. Suberlich HE, Kretsch MJ, Skala JH, Johnson HL, Taylor PC. Folate requirements and metabolism in nonpregnant women. Am J Clin Nutr 1987;46:1016-1028.
8. Rothman KJ, Moore LL, Singer MR, Nguyen U-SDT, Mannino S, Milunsky A. Teratogenicity of high vitamin A intake. N Engl J Med 1995;333:1369-1373.
9. Botto LD, Loffredo C, Scanlon KS, Khoury MJ, Ferencz C, Moore CA, Correa-Villaseñor A, Wilson PD, Erickson JD. Cardiac outflow tract defects in the offspring of mothers who took retinol supplements (Abstract). Proceedings of the Greenwood Genetic Center 1997;16:146-147.
10. Laurence KM, James M, Miller MH, Tennant GB, Campbell H. Double-blind randomized controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. BMJ 1981;282:1509-1511.
11. Smithells RW, Sheppard S, Wild J, Schorah CJ. Prevention of neural tube defect recurrences in Yorkshire. Lancet 1989;2:498-499.
12. Mulinare J, Cordero JF, Erickson JD, Berry RJ. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 1988;260: 3141-3145.
13. Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, Rothman KJ, Willett W. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989;262:2847-2852.
14. Bower C, Stanley FJ. Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia. Med J Aust 1989;150:613-619.
15. Vergel RG, Sánchez LR, Heredero BL, Rodríguez PL, Martínez AJ. Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenat Diagn 1990;10:149-152.
16. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;338: 131-137.
17. Czeizel AE, Dudas I. Prevention of first occurrence of neural-tube defects by periconceptional vitamin supplements. N Engl J Med 1992;327:1832-1835.
18. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 1993;269:1257-1261.
19. Shaw GM, Schaffer D, Verlie E, Morland K, Harris JA. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 1995;6:219-226.
20. Pexieder T. Overview: proper laboratory practice in experimental studies of abnormal cardiovascular development. In: Clark EB, Markwald RR, Takao A, eds. Developmental Mechanisms of Heart Disease. Armonk, NY: Futura Publishing, 1995;169-174.